Alpha Modus (AMOD) Sues Walgreens for Patent Infringement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Alpha Modus Sues Walgreens for Patent Infringement, Strengthening Its Leadership in AI-Driven Retail Innovation
February 4, 2025 8:00 AM ESTCORNELIUS, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (Company) announced today that its wholly owned subsidiary, Alpha Modus, Corp. (Alpha Modus), has filed a patent infringement lawsuit that also alleges willful infringement against Walgreens Co. (Walgreens) in the United States District Court for the Eastern District of Texas. This legal action underscores Alpha Moduss unwavering commitment to protecting its groundbreaking AI-driven retail technology and further solidifies its leadership in the rapidly evolving retail innovation landscape.
Championing Innovation and Protecting Shareholder Value
Alpha Modus has transformed AI-powered retail engagement... More
